Polyrizon Ltd. (PLRZ)

NASDAQ·Healthcare·Biotechnology

$11.33

-2.16%

Mkt Cap $13.52M

No analyst coverage available

We don't have analyst ratings or price target data for Polyrizon Ltd. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.